Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
Authors
Keywords
-
Journal
Circulation-Heart Failure
Volume 12, Issue 4, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-04-10
DOI
10.1161/circheartfailure.118.005565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resident fibroblast expansion during cardiac growth and remodeling
- (2018) Malina J. Ivey et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Small proline-rich protein 2B drives stress-dependent p53 degradation and fibroblast proliferation in heart failure
- (2018) Ryan M. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
- (2016) Yasunori Suematsu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Genetic lineage tracing defines myofibroblast origin and function in the injured heart
- (2016) Onur Kanisicak et al. Nature Communications
- Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage
- (2015) Hui-Yu Bai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Thioredoxin-Interacting Protein Is a Biomechanical Regulator of Src Activity
- (2014) Oded N. Spindel et al. CIRCULATION RESEARCH
- Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels
- (2014) M. A. Trembley et al. DEVELOPMENT
- Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
- (2014) Kazuomi Kario et al. HYPERTENSION
- Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
- (2014) Thomas Moore-Morris et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C
- (2014) Kailash N. Pandey Frontiers in Molecular Neuroscience
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- The Actin–MRTF–SRF Gene Regulatory Axis and Myofibroblast Differentiation
- (2012) Eric M. Small Journal of Cardiovascular Translational Research
- Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation
- (2011) Kailash N. Pandey CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Heart Disease and Stroke Statistics—2009 Update
- (2009) et al. CIRCULATION
- Differential VASP phosphorylation controls remodeling of the actin cytoskeleton
- (2009) P. M. Benz et al. JOURNAL OF CELL SCIENCE
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1
- (2008) Prerna Kumar et al. BIOSCIENCE REPORTS
- Cardiac Plasticity
- (2008) Joseph A. Hill et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started